These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34688332)

  • 21. Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder.
    Sharma M; Sharma S; Wadhwa J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):45-55. PubMed ID: 30663410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy.
    Jain K; Kumar RS; Sood S; Dhyanandhan G
    Curr Drug Deliv; 2013 Oct; 10(5):493-9. PubMed ID: 23410069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
    Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
    Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation.
    Muhsin MD; George G; Beagley K; Ferro V; Wang H; Islam N
    Mol Pharm; 2016 May; 13(5):1455-66. PubMed ID: 26998555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part I: influence of process parameters on their preparation studied by experimental design.
    Achouri D; Hornebecq V; Piccerelle P; Andrieu V; Sergent M
    Drug Dev Ind Pharm; 2015 Jan; 41(1):109-15. PubMed ID: 24188327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
    Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
    Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of selegiline-loaded bio-nanosuspension for the management of depression using novel bio-retardant from
    Tyagi Y; Madhav NVS
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1351-1360. PubMed ID: 31084445
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysis of Riboflavin Compounds in the Rabbit Cornea In Vivo.
    Hammer A; Rudaz S; Guinchard S; Kling S; Richoz O; Hafezi F
    Curr Eye Res; 2016 Sep; 41(9):1166-72. PubMed ID: 26766395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    Khan S; Warade S; Singhavi DJ
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Katara R; Majumdar DK
    Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
    Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.
    El-Habashy SE; Allam AN; El-Kamel AH
    Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery.
    Ambhore NP; Dandagi PM; Gadad AP
    Drug Deliv Transl Res; 2016 Feb; 6(1):48-56. PubMed ID: 26545605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trimethyl chitosan nanoparticles for ocular baicalein delivery: Preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation.
    Li J; Jin X; Yang Y; Zhang L; Liu R; Li Z
    Int J Biol Macromol; 2020 Aug; 156():749-761. PubMed ID: 32320806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiality of microemulsion systems in treatment of ophthalmic disorders: Keratoconus and dry eye syndrome - In vivo study.
    Lidich N; Garti-Levy S; Aserin A; Garti N
    Colloids Surf B Biointerfaces; 2019 Jan; 173():226-232. PubMed ID: 30300828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of ocular efficacy of aceclofenac using biodegradable PLGA nanoparticles: formulation and characterization.
    Katara R; Sachdeva S; Majumdar DK
    Drug Deliv Transl Res; 2017 Oct; 7(5):632-641. PubMed ID: 28812225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part II: optimization of formulation variables using experimental design.
    Achouri D; Sergent M; Tonetto A; Piccerelle P; Andrieu V; Hornebecq V
    Drug Dev Ind Pharm; 2015 Mar; 41(3):493-501. PubMed ID: 24520866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel.
    Pandurangan DK; Bodagala P; Palanirajan VK; Govindaraj S
    Int J Pharm Investig; 2016; 6(1):56-62. PubMed ID: 27014620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance.
    Jahangir MA; Khan R; Sarim Imam S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):66-78. PubMed ID: 29226729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.